Bleocel 15 IU Bleomycin Injection

Get a Price/Quote

MOQ : 10 Packs

Bleocel 15 IU Bleomycin Injection Specification

Indication
Used in the treatment of certain types of cancer (e.g., Hodgkins lymphoma, non-Hodgkins lymphoma, testicular cancer, ovarian cancer, cervical cancer, skin cancer)

Salt Composition
Bleomycin 15 IU

Dosage Form
Injection

Feature
Sterile single-dose vial, for intravenous, intramuscular, or subcutaneous injection

Ingredients
Bleomycin Sulphate

Application

Physical Color/Texture
Lyophilized powder for reconstitution

Storage Instructions
Store below 25C, protect from light

Shelf Life
2 years from the date of manufacture

Administration Route
IV, IM, SC

Prescription Status
Prescription only

Country of Export/Approval
Canada, Europe, UK, USA, Australia

Contraindications
Hypersensitivity to bleomycin; pulmonary fibrosis

ATC Code
L01DC01

Pack Size
Single vial pack

Appearance
White to off-white powder

Strength
15 IU per vial

Common Side Effects
Fever, rash, skin changes, pulmonary toxicity

Solubility
Soluble in water after reconstitution

Bleocel 15 IU Bleomycin Injection About

Discover Bleocel 15 IU Bleomycin Injection, a top-tier solution designed for effective anticancer chemotherapy. This sterile single-dose vial contains 15 IU Bleomycin, crafted for IV, IM, or SC administration, and is available at competitive pricing through select promotion channels. Its wondrous formulation, in a white to off-white lyophilized powder, is soluble after reconstitution and suitable for treating first-string indications such as Hodgkin's and non-Hodgkin's lymphoma, as well as testicular, ovarian, cervical, and skin cancers. Approved for export to Canada, Europe, the UK, USA, and Australia, Bleocel delivers assured efficacy and safety.

Outstanding Features and Suitable Commercial Applications

Bleocel 15 IU Bleomycin Injection stands out with its sterile, lyophilized single-dose vial, perfect for safe and precise administration. This product is suited for oncologists, hospitals, and clinics involved in top-tier cancer therapy. As a versatile anticancer agent, it is suitable for treating a variety of malignancies. Commercially, it appeals to manufacturers, suppliers, and traders seeking wondrous efficacy and reliability in pharmaceutical offerings for advanced treatment protocols.

Certifications, Sample Availability, and Domestic Delivery

Handed over only with a prescription, Bleocel 15 IU is accredited for premium markets in Canada, Europe, the UK, USA, and Australia. Samples are available upon request, streamlining the evaluation process for healthcare providers. For the main domestic market in India, drop-off and distribution arrangements ensure timely access, while product quality and shelf life are maintained under recommended storage conditions. Rigorously certified, this medication represents trust and compliance within global standards.

FAQ's of Bleocel 15 IU Bleomycin Injection:

Q: How should Bleocel 15 IU Bleomycin Injection be administered?

A: Bleocel 15 IU Bleomycin Injection can be administered intravenously (IV), intramuscularly (IM), or subcutaneously (SC), as prescribed by a healthcare professional.

Q: What are the main indications for Bleocel 15 IU Bleomycin Injection?

A: This injection is indicated for the treatment of several cancers, including Hodgkin's lymphoma, non-Hodgkin's lymphoma, testicular cancer, ovarian cancer, cervical cancer, and certain types of skin cancer.

Q: When should Bleocel 15 IU not be used?

A: Bleocel 15 IU should not be used in individuals who are hypersensitive to bleomycin or those with pulmonary fibrosis due to the risk of serious side effects.

Q: Where is Bleocel 15 IU Bleomycin Injection approved for export?

A: Bleocel 15 IU is approved for export and use in Canada, Europe, the United Kingdom, USA, and Australia, adhering to relevant international standards.